Home » Topics » Regulatory

Regulatory
RSS

Vyteris submits NDA for lidocaine patch

June 5, 2002

FDA approves Imagent for ultrasound imaging of the heart

June 4, 2002

Room-temperature Betaseron launched in U.S. for relapsing-remitting MS

June 4, 2002

Biovail licenses Metformin GR from DepoMed

June 4, 2002

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

June 3, 2002

Neurontin receives FDA approval for postherpetic neuralgia

June 3, 2002

Abreva approved for OTC sale in Canada, Korea

June 3, 2002

Ethypharm and Aventis collaborate to create Flash version of Allegra

May 29, 2002

Eligard 7.5 mg launched for advanced prostate cancer

May 29, 2002

MicardisPlus approved in E.U. for hypertension

May 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 14, 2025.
Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal
BioWorld
With a packed pipeline of drug candidates targeting multiple markers of cancer, Bayer AG signed on for a new project, this time going after the KRAS pathway with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 13, 2025.
FDA warning raises Whoop's blood pressure
BioWorld MedTech
The FDA’s warning letter to Whoop Inc. resurrects questions about the agency’s observance of the 21st Century Cures Act in that the warning letter stakes out the...
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...